tyrphostin ag 1024 has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kisielewska, J; Klein, A; Ligeza, J | 1 |
| Cheng, HY; Ko, FH | 1 |
2 other study(ies) available for tyrphostin ag 1024 and paclitaxel
| Article | Year |
|---|---|
The effect of tyrosine kinase inhibitors, tyrphostins: AG1024 and SU1498, on autocrine growth of prostate cancer cells (DU145).
Topics: Antineoplastic Agents; Apoptosis; Autocrine Communication; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cinnamates; Culture Media, Conditioned; Dose-Response Relationship, Drug; Humans; Male; Paclitaxel; Prostatic Neoplasms; Protein Kinase Inhibitors; Tyrphostins | 2008 |
Studying the enhancement of programmed cell death by combined AG1024 and paclitaxel in a model of chronic myelogenous leukemia.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Drug Delivery Systems; Drug Therapy, Combination; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Paclitaxel; Tyrphostins; Up-Regulation | 2014 |